2012年
-
Fukuoka K, Sasaki A, Yanagisawa T, Suzuki T, Wakiya K, Adachi J, Mishima K, Fujimaki T, Matsutani M, Nishikawa R.:
Pineal parenchymal tumor of intermediate differentiation with marked elevation of MIB-1 labeling index. Brain Tumor Pathol. 29(4), 2012
-
Adachi J, Mishima K, Wakiya K, Suzuki T, Fukuoka K, Yanagisawa T, Matsutani M, Sasaki A, Nishikawa R.:
O⁶-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment. J Neurooncol. 107(1), 2012
-
Mishima K.:
Treatment of recurrent primary central nerve system lymphoma. Gan To Kagaku Ryoho. 39(6), 2012
-
Feng H, Hu Bo, Jarzynka MJ, Li Yanxin, Keezer S, Johns TG, Tang CK, Hamilton RL, Vuori K, Nishikawa R, Sarkaria JN, Fenton T, Cheng T, Furnari FB, Cavenee WK ,Cheng S-Y. :
Phosphorylation fo dedicator of cytokinesis 1 (Dock180) at tyroisine residue Y722 by Src family kinases mediates EGFRｖIII-driven Glioblastoma tumorigenesis. Proc Natl Acad Sci USA 109:3018-3023, 2012
-
Ogura T, Satoh A, Ooigawa H, Sugiyama T, Takeda R, Fushihara G, Yoshikawa S, okada D, Suzuki H, Araki R, Ishihara S, Nishikawa R, Kurita H. :
Characteristics and prognostic value of acute catecholamine surge in patients with aneurysmal subarachnoid hemorrhage. Neuro Res 34:484-490, 2012.
-
Mukasa A, Takayanagi S, Saito K, Shibahara J, Tabei Y, Furuya K, Ide T, Narita Y, Nishikawa R, Ueki K, Saito N. :
Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients. Cancer Sci 103:587-592, 2012.
-
Ichimura K, Nishikawa R, Matsutani M. :
Molecular markers in pediatric neuro-oncology. Neuro-Oncol 14:90-99, 2012.
-
Nishikawa R.:
Resection of PCNSL, if safely possible, seems to be better than biopsy: challenging a paradigm? NeuroOncol 14:1423, 2012.
-
Nishikawa R. :
Diffuse intrinsic pontine gliomas: new waves. Neuro-Oncol 14:245, 2012.
-
Nagane M, Nishikawa R, Narita Y, Kobayashi H, Takano S, Shinoura N, Aoki T, Sugiyama K, Kuratsu J, Muragaki Y, Sawamura Y, Matsutani M. :
Phase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma. Jpn J Clin Oncol 42:887-895, 2012.
-
Motomura K, Natsume A, Watanabe R, Ito I, Kato Y, Momota H, Nishikawa R, Mishima K, Nakasu Y, Abe T, Namba H, Nakazato Y, Tashiro H, Takeuchi I, Mori T, Wakabayashi T. :
Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastoma. Cancer Sci 103:1871-1879, 2012.
-
Shibui S, Narita Y, Mizusawa J, Beppu T, Ogasawara K, Sawamura Y, Kobayashi H, Ninshikawa R, Mishima K, Muragaki Y, Maruyama T, Kuratsu J, Nakamura H, Kochi M, Minamida Y, Yamaki T, Kumabe T, Tominaga T, Kayama T, Sakurada K, Nagane M, Kobayashi K, Nakamura H, Ito T, Yazaki T, Sasaki H, Tanaka K, Takahashi H, Asai A, Todo, T, Wakabayashi T, Takahashi T, Takano S, Fujimaki T, Sumi M, Miyatake Y, Nakazato Y, Sato, A, Fukuda H, Nomura K. :
Randomized tiral of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305). Cancer Chemother Pharmacol 71:511-521, 2012.